Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/96961
Title: Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain
Author: Darbà, Josep
Kaskens, Lisette
Sorio Vilela, Francesc
Lothgren, Mickael
Keywords: Anàlisi cost-benefici
Menopausa
Osteoporosi
Cost effectiveness
Menopause
Osteoporosis
Issue Date: Feb-2015
Publisher: Dove Medical Press
Abstract: The objective of this study was to estimate the cost-effectiveness of denosumab for fracture prevention compared with no treatment, generic bisphosphonates, and strontium ranelate in a cohort of osteoporotic postmenopausal women in Spain.
Note: Reproducció del document publicat a: http://dx.doi.org/10.2147/CEOR.S78349
It is part of: Clinicoeconomics and Outcomes Research, 2015, vol. 2015, num. 7, p. 105-117
Related resource: http://dx.doi.org/10.2147/CEOR.S78349
URI: http://hdl.handle.net/2445/96961
ISSN: 1178-6981
Appears in Collections:Articles publicats en revistes (Economia)

Files in This Item:
File Description SizeFormat 
649914.pdf755.29 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons